CID 49831257

Filgotinib

Structural Information

Molecular Formula
C21H23N5O3S
SMILES
C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5
InChI
InChI=1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27)
InChIKey
RIJLVEAXPNLDTC-UHFFFAOYSA-N
Compound name
N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

189
References

6803
Patents

425.15216 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 426.15944 202.6
[M+Na]+ 448.14138 212.2
[M-H]- 424.14488 210.9
[M+NH4]+ 443.18598 207.0
[M+K]+ 464.11532 204.9
[M+H-H2O]+ 408.14942 193.2
[M+HCOO]- 470.15036 215.1
[M+CH3COO]- 484.16601 210.2
[M+Na-2H]- 446.12683 203.2
[M]+ 425.15161 206.0
[M]- 425.15271 206.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe